Alzheimer Society of Canada home page Click here for more information
FrançaisHomeContact Our OfficesE-mail Us

Site Search
Donate Now
About the Society
What We Do
Vision and Mission
History of the Society
Board of Directors
Society Study
Policy Statements
Advocacy
Annual Report
Financial Information
TV Public Service Announcement
Alzheimer's Disease
I Have Alzheime Disease
Alzheimer Care
Safely Home Registry
Treatment
Research
Rising Tide
Healthy Brain
Forums
Creative Space

How You Can Help
News and Events
Resources
Media Centre
Site Map

 
 

Alzheimer Society: Policy Statements
   
 
In this section:
Introduction
Statements:
Medications on Provincial Formularies
Stem Cell Research
Population Screening for Dementia
Related pages:
Ethical Guidelines
Guidelines for Care

[Please note that the material on this page was current when it was first posted. For up-to-date information on this topic, visit the Treatment section.]

Alzheimer Society of Canada Statement on the Inclusion of HPB-approved Medications on Provincial Formularies

Revised May 11, 2000

With treatment options for Alzheimer's disease available, it is important that they be accessible to all those who might benefit from them. To ensure their availability, the Alzheimer Society of Canada recommends that all drugs deemed safe and effective by Health Canada for the treatment of Alzheimer's disease be included on all provincial formularies.

Back to top

 
Help for Today. Hope for Tomorrow.
Alzheimer Society | Alzheimer's Disease | I Have Alzheimer's Disease
 
Alzheimer Care | Safely Home | Treatment | Research | Healthy Brain
Forums | Creative Space | How You Can Help | News and Events
Resources | Media Centre | Site Map |
Search
Home | Français | Contact Our Offices | E-mail Us
 
Policy Statements : Intro | Medications on Provincial Formularies | Stem Cell Research
Population Screening for Dementia
Related pages:
Ethical Guidelines | Guidelines for Care
 

This page last reviewed/revised November 2006.
© Alzheimer Society of Canada 1997-2009. All rights reserved.
Important Notice and Disclaimer
For comments, suggestions or additional information, contact dben@alzheimer.ca.